SVLSF VI Buys 89,783 TRex Bio Shares at $14 – Boosting Investor Confidence in Biotech Pipeline
SVLSF VI’s latest insider buy of TRex Bio shares at $14.00 shows growing confidence in the company’s phase‑I dermatology pipeline, signaling potential upside as milestones arrive.
3 minutes to read